APCDD1L and non-small cell lung carcinoma: While Collagen XXIII expression has already been suggested as potential biomarker for NSCLC, APCDD1L-AS1 expression is of prognostic value in squamous cell carcinoma and NTRK2 has recently been reported as therapeutic target in combination with tyrosine kinase inhibitors in this tumor entity29–31.